Blanco-ColioLMMartn-VenturaJLde TeresaEFarsangCGawAGensiniGFet al
[Abstract]2021 May 28;41(6):BSR20204250
A Realistic Before-and-After Timeline Before exposure: skin, mole, and health baseline A true baseline would include natural skin tone, existing freckles and moles, recent sun exposure, medications, and skin-cancer risk factors
If I had to rate it: 4.5/5 for brightening, 5/5 for gentleness, and 4.5/5 for fading post-acne spots
24, bbac584
In March 2024, Viking Therapeutics announced positive results from the company's Phase I multiple ascending dose (MAD) clinical trial of an oral tablet formulation of VK2735 , a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, in development for the potential treatment of metabolic disorders such as obesity